Skip to main content
Clinical Trials/NL-OMON32323
NL-OMON32323
Completed
Not Applicable

Efficacy and safety of home treatment versus in hospital treatment with LMWH in patients with non-massive pulmonary embolism - The Hestia Study

GlaxoSmithKline0 sites280 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pulmonary embolism
Sponsor
GlaxoSmithKline
Enrollment
280
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Consecutive patients with proven acute non\-massive, stable PE
  • 2\. Age over 18
  • 3\. Informed consent

Exclusion Criteria

  • 1\. Patients who have had symptoms of PE for longer than 7 days duration
  • 2\. Diagnosis of PE during anticoagulant treatment
  • 3\. Active bleeding, or a very high risk for major bleeding
  • 4\. Severe pain requiring intravenous narcotic analgesia
  • 5\. Medical or social condition which necessitates admission to the hospital for another reason
  • 6\. Pregnancy
  • 7\. Severe renal of liver failure
  • 8\. Previously documented heparin induced thrombocytopenia

Outcomes

Primary Outcomes

Not specified

Similar Trials